Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00685_DB01377_nanopub.RAakh3SIyeZ6prHtLF1EM4vH840zSKpL8hIi-g747kUFc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00685_DB01377 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00685_DB01377 label "DDI between Trovafloxacin and Magnesium oxide - Magnesium may decrease the absorption of orally administered Trovafloxacin. Administer Trovafloxacin 2 hours before or 6 hours after a dose of the magnesium containing agent to minimize the interaction. [drugbank_resource:DB00685_DB01377]" assertion.
- drugbank_resource:DB00685_DB01377 identifier "drugbank_resource:DB00685_DB01377" assertion.
- drugbank_resource:DB00685_DB01377 title "DDI between Trovafloxacin and Magnesium oxide - Magnesium may decrease the absorption of orally administered Trovafloxacin. Administer Trovafloxacin 2 hours before or 6 hours after a dose of the magnesium containing agent to minimize the interaction." assertion.
- drugbank:DB01377 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00685_DB01377 assertion.
- drugbank:DB00685 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00685_DB01377 assertion.